Goldman Sachs Appoints Ben Wallace as Co-Head of Americas M&A

Goldman Sachs has appointed Ben Wallace as co-head of its Mergers and Acquisitions (M&A) division for the Americas, according to an internal memo. Wallace, who became a partner at the firm in 2022, will continue his role as global head of healthcare M&A, a position he has held since joining Goldman Sachs as a managing director in 2018. In his expanded capacity, Wallace will collaborate with Avinash Mehrotra and Brian Haufrect to lead the regional M&A franchise, focusing on strategic direction, business development, and integration across the Americas M&A platform.

Before joining Goldman Sachs, Wallace was a managing director at JPMorgan, where he led M&A across several industry sectors, including healthcare. He joined JPMorgan in 2006 as a summer associate and was promoted to managing director in 2016. During his tenure, he specialized in healthcare transactions and worked on more than $500 billion in announced deals.

Since joining Goldman Sachs in 2018, Wallace has advised on numerous significant transactions, including the $30 billion leveraged buyout of Medline Industries—the largest such deal since the 2008 financial crisis—and the $16.4 billion sale of Varian to Siemens Healthineers. He also played a key role in the $8 billion acquisition of Signify Health by CVS Health.

Wallace's promotion reflects Goldman Sachs' strategic emphasis on the healthcare sector, which has been a focal point for M&A activity due to factors such as aging populations, technological advancements, and regulatory changes. His dual role positions the firm to capitalize on these trends by leveraging his expertise in healthcare M&A while overseeing broader regional transactions.

The appointment also underscores Goldman Sachs' commitment to reinforcing its leadership in M&A advisory services across the Americas. By integrating Wallace's sector-specific knowledge with the firm's regional strategy, Goldman aims to enhance its ability to navigate complex transactions and drive business development in a competitive market.

As of July 11, 2025, Goldman Sachs' stock (GS) is trading at $700.23, reflecting the firm's strong position in the financial sector.

Wallace earned a Bachelor of Arts in Business Economics, magna cum laude, from the University of California, Los Angeles (UCLA), and an MBA from the University of Chicago. He is a member of the UCLA Department of Economics Board of Visitors and a trustee of First Tee, an international nonprofit focused on improving children's life and social skills. He resides in New York City with his wife and four children.

This strategic appointment positions Goldman Sachs to further strengthen its M&A advisory capabilities, particularly in the healthcare sector, and to continue its leadership in the Americas M&A market.